{"id":"https://openalex.org/W4416635456","doi":"https://doi.org/10.1183/13993003.congress-2025.pa3506","title":"Enhancing innovative therapies for pulmonary infections through liposomal encapsulation of tobramycin against Pseudomonas aeruginosa","display_name":"Enhancing innovative therapies for pulmonary infections through liposomal encapsulation of tobramycin against Pseudomonas aeruginosa","publication_year":2025,"publication_date":"2025-09-27","ids":{"openalex":"https://openalex.org/W4416635456","doi":"https://doi.org/10.1183/13993003.congress-2025.pa3506"},"language":"en","primary_location":{"id":"doi:10.1183/13993003.congress-2025.pa3506","doi":"https://doi.org/10.1183/13993003.congress-2025.pa3506","is_oa":false,"landing_page_url":"https://doi.org/10.1183/13993003.congress-2025.pa3506","pdf_url":null,"source":{"id":"https://openalex.org/S4210207896","display_name":"European Respiratory Journal","issn_l":"0903-1936","issn":["0903-1936","1399-3003"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310317833","host_organization_name":"European Respiratory Society","host_organization_lineage":["https://openalex.org/P4310317833"],"host_organization_lineage_names":["European Respiratory Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Mechanisms of lung injury and repair","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Juliana Carrillo Romero","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210087187","display_name":"CIC biomaGUNE","ror":"https://ror.org/004g03602","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I4210087187"]},{"id":"https://openalex.org/I4210121514","display_name":"GAIKER Technology Centre","ror":"https://ror.org/02pwsw017","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210121514"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Juliana Carrillo Romero","raw_affiliation_strings":["1GAIKER Technology Centre, Basque Research and Technology Alliance (BRTA), Center for Cooperative Research in Biomaterials (CIC biomaGUNE), Basque Research and Technology Alliance (BRTA), Zamudio, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1GAIKER Technology Centre, Basque Research and Technology Alliance (BRTA), Center for Cooperative Research in Biomaterials (CIC biomaGUNE), Basque Research and Technology Alliance (BRTA), Zamudio, Spain","institution_ids":["https://openalex.org/I4210087187","https://openalex.org/I4210121514"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Laura Fern\u00e1ndez Mendez","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210087187","display_name":"CIC biomaGUNE","ror":"https://ror.org/004g03602","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I4210087187"]},{"id":"https://openalex.org/I4210099160","display_name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Respiratorias","ror":"https://ror.org/0119pby33","country_code":"ES","type":"facility","lineage":["https://openalex.org/I2801357902","https://openalex.org/I4210099160","https://openalex.org/I4210115082","https://openalex.org/I4387152914"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Laura Fern\u00e1ndez Mendez","raw_affiliation_strings":["2Center for Cooperative Research in Biomaterials (CIC biomaGUNE), Basque Research and Technology Alliance (BRTA), CIBER de Enfermedades Respiratorias (CIBERES), San Sebasti\u00e1n, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Center for Cooperative Research in Biomaterials (CIC biomaGUNE), Basque Research and Technology Alliance (BRTA), CIBER de Enfermedades Respiratorias (CIBERES), San Sebasti\u00e1n, Spain","institution_ids":["https://openalex.org/I4210087187","https://openalex.org/I4210099160"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042342650","display_name":"Ibai Nafarrate","orcid":"https://orcid.org/0000-0002-7014-4881","observed_orcids":["https://orcid.org/0000-0002-7014-4881"]},"institutions":[{"id":"https://openalex.org/I4210121514","display_name":"GAIKER Technology Centre","ror":"https://ror.org/02pwsw017","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210121514"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Ibai Nafarrate","raw_affiliation_strings":["3GAIKER Technology Centre, Basque Research and Technology Alliance (BRTA), Zamudio, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3GAIKER Technology Centre, Basque Research and Technology Alliance (BRTA), Zamudio, Spain","institution_ids":["https://openalex.org/I4210121514"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005275986","display_name":"Gartze Mentxaka","orcid":"https://orcid.org/0000-0003-2238-7771","observed_orcids":["https://orcid.org/0000-0003-2238-7771"]},"institutions":[{"id":"https://openalex.org/I4210121514","display_name":"GAIKER Technology Centre","ror":"https://ror.org/02pwsw017","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210121514"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Gartze Mentxaka","raw_affiliation_strings":["3GAIKER Technology Centre, Basque Research and Technology Alliance (BRTA), Zamudio, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3GAIKER Technology Centre, Basque Research and Technology Alliance (BRTA), Zamudio, Spain","institution_ids":["https://openalex.org/I4210121514"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015812381","display_name":"Adri\u00e1n Garc\u00eda-Salvador","orcid":"https://orcid.org/0000-0002-7311-8312","observed_orcids":["https://orcid.org/0000-0002-7311-8312"]},"institutions":[{"id":"https://openalex.org/I4210121514","display_name":"GAIKER Technology Centre","ror":"https://ror.org/02pwsw017","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210121514"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Adri\u00e1n Garc\u00eda-Salvador","raw_affiliation_strings":["3GAIKER Technology Centre, Basque Research and Technology Alliance (BRTA), Zamudio, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3GAIKER Technology Centre, Basque Research and Technology Alliance (BRTA), Zamudio, Spain","institution_ids":["https://openalex.org/I4210121514"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064485987","display_name":"Jes\u00fas Ru\u00edz-Cabello","orcid":"https://orcid.org/0000-0001-8681-5056","observed_orcids":["https://orcid.org/0000-0001-8681-5056"]},"institutions":[{"id":"https://openalex.org/I110594554","display_name":"Ikerbasque","ror":"https://ror.org/01cc3fy72","country_code":"ES","type":"other","lineage":["https://openalex.org/I110594554"]},{"id":"https://openalex.org/I4210087187","display_name":"CIC biomaGUNE","ror":"https://ror.org/004g03602","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I4210087187"]},{"id":"https://openalex.org/I4210099160","display_name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Respiratorias","ror":"https://ror.org/0119pby33","country_code":"ES","type":"facility","lineage":["https://openalex.org/I2801357902","https://openalex.org/I4210099160","https://openalex.org/I4210115082","https://openalex.org/I4387152914"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Jes\u00fas Ruiz-Cabello","raw_affiliation_strings":["4Center for Cooperative Research in Biomaterials (CIC biomaGUNE), Basque Research and Technology Alliance (BRTA), CIBER de Enfermedades Respiratorias (CIBERES), Ikerbasque, Basque Foundation for Science, San Sebasti\u00e1n, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Center for Cooperative Research in Biomaterials (CIC biomaGUNE), Basque Research and Technology Alliance (BRTA), CIBER de Enfermedades Respiratorias (CIBERES), Ikerbasque, Basque Foundation for Science, San Sebasti\u00e1n, Spain","institution_ids":["https://openalex.org/I110594554","https://openalex.org/I4210087187","https://openalex.org/I4210099160"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022095875","display_name":"Susana Carregal\u2010Romero","orcid":"https://orcid.org/0000-0003-1444-6268","observed_orcids":["https://orcid.org/0000-0003-1444-6268"]},"institutions":[{"id":"https://openalex.org/I110594554","display_name":"Ikerbasque","ror":"https://ror.org/01cc3fy72","country_code":"ES","type":"other","lineage":["https://openalex.org/I110594554"]},{"id":"https://openalex.org/I4210087187","display_name":"CIC biomaGUNE","ror":"https://ror.org/004g03602","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I4210087187"]},{"id":"https://openalex.org/I4210099160","display_name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Respiratorias","ror":"https://ror.org/0119pby33","country_code":"ES","type":"facility","lineage":["https://openalex.org/I2801357902","https://openalex.org/I4210099160","https://openalex.org/I4210115082","https://openalex.org/I4387152914"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Susana Carregal Romero","raw_affiliation_strings":["4Center for Cooperative Research in Biomaterials (CIC biomaGUNE), Basque Research and Technology Alliance (BRTA), CIBER de Enfermedades Respiratorias (CIBERES), Ikerbasque, Basque Foundation for Science, San Sebasti\u00e1n, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Center for Cooperative Research in Biomaterials (CIC biomaGUNE), Basque Research and Technology Alliance (BRTA), CIBER de Enfermedades Respiratorias (CIBERES), Ikerbasque, Basque Foundation for Science, San Sebasti\u00e1n, Spain","institution_ids":["https://openalex.org/I110594554","https://openalex.org/I4210087187","https://openalex.org/I4210099160"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5081005007","display_name":"Felipe Go\u00f1i\u2010de\u2010Cerio","orcid":"https://orcid.org/0000-0002-2029-6369","observed_orcids":["https://orcid.org/0000-0002-2029-6369"]},"institutions":[{"id":"https://openalex.org/I4210121514","display_name":"GAIKER Technology Centre","ror":"https://ror.org/02pwsw017","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210121514"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Felipe Go\u00f1i-De-Cerio","raw_affiliation_strings":["3GAIKER Technology Centre, Basque Research and Technology Alliance (BRTA), Zamudio, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3GAIKER Technology Centre, Basque Research and Technology Alliance (BRTA), Zamudio, Spain","institution_ids":["https://openalex.org/I4210121514"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"PA3506","last_page":"PA3506"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11651","display_name":"Inhalation and Respiratory Drug Delivery","score":0.9585000276565552,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11651","display_name":"Inhalation and Respiratory Drug Delivery","score":0.9585000276565552,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.030500000342726707,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.007499999832361937,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tobramycin","display_name":"tobramycin","score":0.9639999866485596},{"id":"https://openalex.org/keywords/liposomal-drug-delivery","display_name":"liposomal drug delivery","score":0.8479999899864197},{"id":"https://openalex.org/keywords/pseudomonas-aeruginosa","display_name":"Pseudomonas aeruginosa","score":0.9769999980926514},{"id":"https://openalex.org/keywords/pulmonary-infection","display_name":"pulmonary infection","score":0.8980000019073486},{"id":"https://openalex.org/keywords/pegylated-liposomes","display_name":"PEGylated liposomes","score":0.7950000166893005},{"id":"https://openalex.org/keywords/air-liquid-interface-model","display_name":"air-liquid interface model","score":0.7870000004768372},{"id":"https://openalex.org/keywords/mucociliary-clearance","display_name":"mucociliary clearance","score":0.765999972820282},{"id":"https://openalex.org/keywords/inhaled-antibiotics","display_name":"inhaled antibiotics","score":0.5009999871253967},{"id":"https://openalex.org/keywords/lung-retention","display_name":"lung retention","score":0.34599998593330383},{"id":"https://openalex.org/keywords/antibacterial-activity","display_name":"antibacterial activity","score":0.5389999747276306}],"concepts":[{"id":"https://openalex.org/C2778974779","wikidata":"https://www.wikidata.org/wiki/Q1758380","display_name":"Tobramycin","level":4,"score":0.7178000211715698},{"id":"https://openalex.org/C114682108","wikidata":"https://www.wikidata.org/wiki/Q1952044","display_name":"Mucociliary clearance","level":3,"score":0.6589999794960022},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6028000116348267},{"id":"https://openalex.org/C2777637488","wikidata":"https://www.wikidata.org/wiki/Q31856","display_name":"Pseudomonas aeruginosa","level":3,"score":0.5740000009536743},{"id":"https://openalex.org/C185154212","wikidata":"https://www.wikidata.org/wiki/Q410454","display_name":"Liposome","level":2,"score":0.5364999771118164},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5116999745368958},{"id":"https://openalex.org/C2777714996","wikidata":"https://www.wikidata.org/wiki/Q7886","display_name":"Lung","level":2,"score":0.5054000020027161},{"id":"https://openalex.org/C2777312293","wikidata":"https://www.wikidata.org/wiki/Q3649349","display_name":"Mucus","level":2,"score":0.44780001044273376},{"id":"https://openalex.org/C181389837","wikidata":"https://www.wikidata.org/wiki/Q461809","display_name":"Bioavailability","level":2,"score":0.4449999928474426},{"id":"https://openalex.org/C2779820397","wikidata":"https://www.wikidata.org/wiki/Q1392806","display_name":"Drug delivery","level":2,"score":0.4417000114917755},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.42980000376701355},{"id":"https://openalex.org/C2776938444","wikidata":"https://www.wikidata.org/wiki/Q178194","display_name":"Cystic fibrosis","level":2,"score":0.38339999318122864},{"id":"https://openalex.org/C102652120","wikidata":"https://www.wikidata.org/wiki/Q2419430","display_name":"Therapeutic effect","level":2,"score":0.35830000042915344},{"id":"https://openalex.org/C176947019","wikidata":"https://www.wikidata.org/wiki/Q597889","display_name":"Minimum inhibitory concentration","level":3,"score":0.33390000462532043},{"id":"https://openalex.org/C19831878","wikidata":"https://www.wikidata.org/wiki/Q659446","display_name":"Therapeutic index","level":3,"score":0.3273000121116638},{"id":"https://openalex.org/C3019249092","wikidata":"https://www.wikidata.org/wiki/Q274493","display_name":"Antibacterial agent","level":3,"score":0.31610000133514404},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.30480000376701355},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.30160000920295715},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.2946999967098236},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.28299999237060547},{"id":"https://openalex.org/C82085835","wikidata":"https://www.wikidata.org/wiki/Q16142045","display_name":"Aerosolization","level":3,"score":0.27619999647140503},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.27410000562667847},{"id":"https://openalex.org/C13245373","wikidata":"https://www.wikidata.org/wiki/Q3715494","display_name":"Drug carrier","level":3,"score":0.27219998836517334},{"id":"https://openalex.org/C2983812674","wikidata":"https://www.wikidata.org/wiki/Q134808","display_name":"Delivery system","level":2,"score":0.2653000056743622},{"id":"https://openalex.org/C80107235","wikidata":"https://www.wikidata.org/wiki/Q7162625","display_name":"Penetration (warfare)","level":2,"score":0.2635999917984009},{"id":"https://openalex.org/C534529494","wikidata":"https://www.wikidata.org/wiki/Q7891","display_name":"Respiratory system","level":2,"score":0.25589999556541443}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1183/13993003.congress-2025.pa3506","doi":"https://doi.org/10.1183/13993003.congress-2025.pa3506","is_oa":false,"landing_page_url":"https://doi.org/10.1183/13993003.congress-2025.pa3506","pdf_url":null,"source":{"id":"https://openalex.org/S4210207896","display_name":"European Respiratory Journal","issn_l":"0903-1936","issn":["0903-1936","1399-3003"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310317833","host_organization_name":"European Respiratory Society","host_organization_lineage":["https://openalex.org/P4310317833"],"host_organization_lineage_names":["European Respiratory Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Mechanisms of lung injury and repair","raw_type":"proceedings-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9922999739646912,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7160109880","https://openalex.org/W7214753752","https://openalex.org/W2137391554","https://openalex.org/W2156129395","https://openalex.org/W2513585603","https://openalex.org/W2008634019","https://openalex.org/W2121669915","https://openalex.org/W2168053510","https://openalex.org/W2288456615","https://openalex.org/W2111192867"],"abstract_inverted_index":{"Pulmonary":[0],"infections":[1],"caused":[2],"by":[3,35,172],"Pseudomonas":[4],"aeruginosa":[5,94,220],"constitute":[6],"a":[7,26,121,183,245],"therapeutic":[8,73,102],"challenge":[9],"due":[10],"to":[11,56,70,88,91,197,204,227],"the":[12,30,43,47,62,72,105,151,159,179,190,200,238],"ongoing":[13],"difficulties":[14],"in":[15,61,78,96,97,189,237],"developing":[16],"both":[17,143],"effective":[18],"and":[19,39,59,83,117,137,153,166,206,233],"safe":[20],"treatments.":[21],"Inhaled":[22],"tobramycin":[23],"(TB)":[24],"is":[25,54],"reference":[27],"therapy,":[28],"but":[29],"efficacy":[31,103],"may":[32],"be":[33],"limited":[34,40],"its":[36],"rapid":[37],"clearance":[38,232],"penetration":[41],"into":[42],"pulmonary":[44,139,221],"mucus.":[45],"Therefore,":[46],"development":[48],"of":[49,66,75,104,158],"advanced":[50],"drug":[51],"delivery":[52],"systems":[53],"critical":[55],"enhance":[57],"retention":[58,236],"bioavailability":[60],"lung.":[63],"The":[64,101],"objective":[65],"this":[67],"study":[68],"was":[69,107,162],"evaluate":[71],"capacity":[74],"TB":[76,90,168],"encapsulated":[77],"liposomes":[79],"without":[80],"PEG":[81,85],"(LP-TB)":[82],"with":[84,142,146],"(LPPEG-TB)":[86],"compared":[87,203],"free":[89,167,207],"treat":[92],"P.":[93,147,219],"infection":[95],"vitro":[98],"lung":[99,123,173],"models.":[100],"compounds":[106],"evaluated":[108],"at":[109,125],"different":[110],"time":[111,185],"points":[112],"(24":[113],"h,":[114],"48":[115],"h":[116],"72":[118],"h)":[119],"using":[120],"cellular":[122,242],"model":[124],"air-liquid":[126],"interface":[127],"through":[128,199],"Vitrocell":[129],"Cloud":[130],"12":[131],"exposure":[132],"system":[133],"(VITROCELL\u00ae":[134],"Systems":[135],"GmbH)":[136],"artificial":[138],"mucus":[140,201,229],"(APM),":[141],"models":[144],"infected":[145],"aeruginosa.":[148],"After":[149],"testing":[150],"safety":[152],"minimum":[154],"inhibitory":[155],"concentration":[156],"(MIC)":[157],"compounds,":[160],"it":[161],"observed":[163],"that":[164,212],"LP-TB":[165,205],"were":[169],"rapidly":[170],"internalised":[171],"cells,":[174],"while":[175],"LPPEG-TB":[176,193,213],"remained":[177],"on":[178],"cell":[180,239],"membrane":[181,240],"for":[182,217],"longer":[184],"before":[186,241],"internalisation.":[187],"Furthermore,":[188],"APM":[191],"model,":[192],"demonstrated":[194],"greater":[195],"ability":[196,226],"migrate":[198],"layer":[202],"TB.":[208],"These":[209],"results":[210],"suggest":[211],"are":[214],"promising":[215],"candidates":[216],"treating":[218],"infections,":[222],"as":[223],"their":[224,234],"increased":[225],"penetrate":[228],"reduces":[230],"mucociliary":[231],"prolonged":[235],"uptake":[243],"allows":[244],"more":[246],"sustained":[247],"antibacterial":[248],"activity.":[249]},"counts_by_year":[],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2025-11-25T00:00:00"}